Clinical trial · Observational
Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients
Measuring Urinary Nano Particles and Arsenic and Comparing Them to Cystoscopic Findings and Urinary Cytology in Patients Suspected With Urinary Bladder Malignancy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In many of urothelial carcinoma patients, one does not find common risk factors such as smoking. The medical center is located in an industrial city with known air and water pollution. The investigators decided to check the presence of nano particles and traces of metals in urinary samples of patients known and suspected for urothelial carcinoma and compare the results to both cystoscopic and cytological findings. The patients will fill a validated epidemiological respiratory disease survey and the results will be compared to a control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| without intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- study group
- description
- Patients that need that need cystoscopy due to suspicion/known bladder malignancy.
- interventionNames
- Other: without intervention
- label
- control group
- description
- Patients that need cystoscopy due to others reasons than malignancy.
- interventionNames
- Other: without intervention
Primary outcomes (1)
- measure
- levels of nano particles and arsenic in urine
- timeFrame
- one year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Study group : 1. Patients that need cystoscopy due to suspicion/known bladder malignancy. 2. Patients that can read, understand and sign an informed consent form. Control group: 1. Patients that need cystoscopy due to others reasons than malignancy. 2. Patients that present to the Department of Urology for surgery unrelated to malignancy of the urinary system ( prostatectomy, Incontinence repair, circumcision, hydrocele/ varicocele repair, ureteroscopy etc). Exclusion Criteria: Study group: 1. Patients receiving bladder irrigations, pregnant women, children and those with impaired judgment 2. Patients with a technically improper urine test. Control group 1. Patients receiving bladder irrigations, pregnant women, children and those with impaired judgment 2. Patients with a technically improper urine test.
References
Publications (0)
Data not yet available